The Journal of Pediatrics
Volume 155, Issue 2 , Pages 170-175 , August 2009

Blood Aldosterone-to-Renin Ratio, Ambulatory Blood Pressure, and Left Ventricular Mass in Children

  • Rongling Li, MD, PhD, MPH

      Affiliations

    • Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN
    • Corresponding Author InformationReprint requests: Rongling Li, MD, PhD, Department of Preventive Medicine, University of Tennessee Health Science Center, 66 N Pauline Street, Suite 633, Memphis, TN 38163.
    • ,
  • Phyllis A. Richey, PhD

      Affiliations

    • Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN
    • Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN
    • ,
  • Thomas G. DiSessa, MD

      Affiliations

    • Department of Pediatrics, University of Kentucky Medical School, Lexington, KY
    • ,
  • Bruce S. Alpert, MD

      Affiliations

    • Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN
    • General Clinical Research Center, Children's Foundation Research Center at Le Bonheur Children's Medical Center, Memphis, TN
    • ,
  • Deborah P. Jones, MD, MS

      Affiliations

    • Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN
    • General Clinical Research Center, Children's Foundation Research Center at Le Bonheur Children's Medical Center, Memphis, TN

Received 27 August 2008 ,Revised 14 January 2009 ,Accepted 12 February 2009.

References 

  1. Tiu SC, Choi CH, Shek CC, Ng YW, Chan FK, Ng CM, et al. The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab. 2005;90:72–78
  2. Newton-Cheh C, Guo CY, Gona P, Larson MG, Benjamin EJ, Wang TJ, et al. Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample. Hypertension. 2007;49:846–856
  3. Mahmud A, Feely J. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension. Am J Hypertens. 2005;18:50–55
  4. Soergel M, Kirschstein M, Busch C, Danne T, Gellermann J, Holl R, et al. Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr. 1997;130:178–184
  5. Richey PA, Disessa TG, Hastings MC, Somes GW, Alpert BS, Jones DP. Ambulatory blood pressure and increased left ventricular mass in children at risk for hypertension. J Pediatr. 2008;152:343–348
  6. Jones DP, Richey PA, Alpert BS. Validation of the AM5600 ambulatory blood pressure monitor in children and adolescents. Blood Press Monit. 2008;13:349–351
  7. Richey PA, Jones CL, Harshfield GA, Somes GW, Johnson KC, Bailey JE, et al. The AM5600 ambulatory blood pressure recording system. Blood Press Monit. 1997;2:193–195
  8. Lai WW, Geva T, Shirali GS, Frommelt PC, Humes RA, Brook MM, et al. Guidelines and standards for performance of a pediatric echocardiogram: a report from the Task Force of the Pediatric Council of the American Society of Echocardiography. J Am Soc Echocardiogr. 2006;19:1413–1430
  9. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450–458
  10. Daniels SR. Hypertension-induced cardiac damage in children and adolescents. Blood Press Monit. 1999;4:165–170
  11. Daniels SR, Meyer RA, Liang YC, Bove KE. Echocardiographically determined left ventricular mass index in normal children, adolescents and young adults. J Am Coll Cardiol. 1988;12:703–708
  12. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol. 1992;20:1251–1260
  13. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293–2300
  14. Flack JM, Grimm RH, Staffileno BA, Elmer P, Yunis C, et al. New salt-sensitivity metrics: variability-adjusted blood pressure change and the urinary sodium-to-creatinine ratio. Ethn Dis. 2002;12:10–19
  15. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat. 2002;11:1–190
  16. Kleinbaum DG, Kupper LL, Muller KE. Applied Regression Analysis and Other Multivariable Methods. 2nd edition. Boston: PWS-Kent; 1988;
  17. Chen W, Srinivasan SR, Berenson GS. Plasma renin activity and insulin resistance in African-American and white children: the Bogalusa Heart Study. Am J Hypertens. 2001;14:212–217
  18. Bloem LJ, Manatunga AK, Pratt JH. Racial difference in the relationship of an angiotensin I–converting enzyme gene polymorphism to serum angiotensin I–converting enzyme activity. Hypertension. 1996;27:62–66
  19. He J, Klag MJ, Appel LJ, Charleston J, Whelton PK. The renin-angiotensin system and blood pressure: differences between blacks and whites. Am J Hypertens. 1999;12:555–562
  20. Stewart AD, Millasseau SC, Dawes M, Kyd PA, Chambers JB, Ritter JM, et al. Aldosterone and left ventricular hypertrophy in Afro-Caribbean subjects with low renin hypertension. Am J Hypertens. 2006;19:19–24
  21. Aviv A, Hollenberg NK, Weder AB. Sodium glomerulopathy: tubuloglomerular feedback and renal injury in African Americans. Kidney Int. 2004;65:361–368
  22. Saha C, Eckert GJ, Ambrosius WT, Chun TY, Wagner MA, Zhao Q, et al. Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension. Hypertension. 2005;46:481–487
  23. Schmidt BM, Schmieder RE. Aldosterone-induced cardiac damage: focus on blood pressure–independent effects. Am J Hypertens. 2003;16:80–86
  24. Barbato A, Russo P, Siani A, Folkerd EJ, Miller MA, Venezia A, et al. Aldosterone synthase gene (CYP11B2) C-344T polymorphism, plasma aldosterone, renin activity and blood pressure in a multi-ethnic population. J Hypertens. 2004;22:1895–1901
  25. Zhu H, Sagnella GA, Dong Y, Miller MA, Onipinla A, Markandu ND, et al. Molecular variants of the sodium/hydrogen exchanger type 3 gene and essential hypertension. J Hypertens. 2004;22:1269–1275
  26. El-Gharbawy AH, Nadig VS, Kotchen JM, Grim CE, Sagar KB, Kaldunski M, et al. Arterial pressure, left ventricular mass, and aldosterone in essential hypertension. Hypertension. 2001;37:845–850
  27. Pratt JH, Jones JJ, Miller JZ, Wagner MA, Fineberg NS. Racial differences in aldosterone excretion and plasma aldosterone concentrations in children. N Engl J Med. 1989;321:1152–1157
  28. Grim CE, Cowley AW, Hamet P, Gaudet D, Kaldunski ML, Kotchen JM, et al. Hyperaldosteronism and hypertension: ethnic differences. Hypertension. 2005;45:766–772
  29. Flynn JT, Alderman MH. Characteristics of children with primary hypertension seen at a referral center. Pediatr Nephrol. 2005;20:961–966
  30. Harshfield GA, Pulliam DA, Alpert BS, Stapleton FB, Willey ES, Somes GW. Ambulatory blood pressure patterns in children and adolescents: influence of renin-sodium profiles. Pediatrics. 1991;87:94–100
  31. Weidmann P, Beretta-Piccoli C, Ziegler WH, Keusch G, Gluck Z, Reubi FC. Age versus urinary sodium for judging renin, aldosterone, and catecholamine levels: studies in normal subjects and patients with essential hypertension. Kidney Int. 1978;14:619–628
  32. Rocha R, Funder JW. The pathophysiology of aldosterone in the cardiovascular system. Ann N Y Acad Sci. 2002;970:89–100
  33. Blacher J, Amah G, Girerd X, Kheder A, Ben Mais H, London GM, et al. Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension. Am J Hypertens. 1997;10:1326–1334
  34. Vasan RS, Evans JC, Larson MG, Wilson PW, Meigs JB, Rifai N, et al. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med. 2004;351:33–41
  35. Velagaleti RS, Pencina MJ, Murabito JM, Wang TJ, Parikh NI, D'Agostino RB, et al. Long-term trends in the incidence of heart failure after myocardial infarction. Circulation. 2008;118:2057–2062
  36. Brown NJ. Aldosterone and vascular inflammation. Hypertension. 2008;51:161–167
  37. Marchesi C, Paradis P, Schiffrin EL. Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol Sci. 2008;29:367–374
  38. Engeli S, Boschmann M, Frings P, Beck L, Janke J, Titze J, et al. Influence of salt intake on renin-angiotensin and natriuretic peptide system genes in human adipose tissue. Hypertension. 2006;48:1103–1108

 Supported by grants from the Children's Foundation Research Center at Le Bonheur Children's Medical Center and the University of Tennessee Health Science Center, the US Public Health Service (MO1 RR-00211), and the National Institutes of Health (NHLBI 5K23HL83910-2). The authors declare no conflicts of interest.

PII: S0022-3476(09)00149-8

doi: 10.1016/j.jpeds.2009.02.029

The Journal of Pediatrics
Volume 155, Issue 2 , Pages 170-175 , August 2009

Article Tools

* Image Usage & Resolution